Equities
  • Price (EUR)64.00
  • Today's Change0.28 / 0.44%
  • Shares traded25.00
  • 1 Year change33.72%
  • Beta0.9373
Data delayed at least 15 minutes, as of Dec 06 2019 13:42 GMT.
More ▼

Profile data is unavailable for this security.

About the company

Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company's segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States. The Global segment includes revenue contributions and expenditures linked to business activity in Aruba, Australia, Austria, the Bahamas, Belgium, Bermuda, Brazil, Canada, Cayman Islands, Chile, Denmark, Egypt, England, Finland, France, Germany, Guam, India, Ireland, Kuwait, Luxembourg, Malaysia, Mexico, the Netherlands, Norway, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovakia, Spain, Sweden, Switzerland and the United Arab Emirates. The Company's solutions are offered on the unified Cerner Millennium architecture and on the HealtheIntent cloud-based platform.

  • Revenue in USD (TTM)5.62bn
  • Net income in USD506.44m
  • Incorporated1986
  • Employees29.20k
  • Location
    Cerner Corp2800 Rock Creek PkwyKANSAS CITY 64117-2521United StatesUSA
  • Phone+1 (816) 221-1024
  • Fax+1 (302) 655-5049
  • Websitehttps://www.cerner.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
CERN:NSQ since
announced
Transaction
value
Ablevets LLCAnnounced18 Oct 201918 Oct 2019Announced3.91%--
Data delayed at least 15 minutes, as of Dec 05 2019 21:00 GMT.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.